Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The MaRS Investment Accelerator Fund (IAF) was established in 2008 and is headquartered in Ontario, Canada. This early-stage venture capital fund is dedicated to supporting technology founders across various sectors. Since its inception, MaRS IAF has focused on providing consistent, long-term support to companies within the innovation ecosystem, helping them navigate the complexities of growth and development.
Currently, MaRS IAF manages a portfolio of over 100 companies, primarily in sectors such as enterprise software, healthtech, cleantech, and deeptech. The fund's commitment to fostering innovation is evident in its investment strategy, which emphasizes the importance of building globally competitive businesses. The team at MaRS IAF leverages extensive networks and expertise to assist founders in achieving their goals.
MaRS IAF invests in early-stage technology companies, with a particular emphasis on sectors including enterprise software, healthtech, cleantech, and deeptech. The fund typically provides initial investments ranging from C$50K to C$500K, supporting companies from the seed stage through to growth equity. This investment strategy allows MaRS IAF to engage with a diverse range of startups, helping them scale effectively.
The fund's approach is characterized by a commitment to leveraging its networks and expertise to assist founders in building competitive businesses on a global scale. MaRS IAF seeks to partner with founders who demonstrate strong potential and a clear vision for their companies, ensuring that they receive the necessary support to thrive in their respective markets.
MaRS IAF has built a diverse portfolio of over 100 companies, primarily focusing on sectors such as enterprise software, healthtech, cleantech, and deeptech. While specific names and descriptions of portfolio companies are not provided, the fund's investment strategy emphasizes supporting innovative technology firms that are poised for growth.
The portfolio reflects the fund's commitment to investing in early-stage companies that are developing solutions to address significant challenges in their industries. By concentrating on these sectors, MaRS IAF positions itself to capitalize on emerging trends and technologies that have the potential to reshape the market landscape.
William Ma - Senior Director, Investments. William has extensive experience in venture capital and has led numerous successful investments in technology companies.
Robbie Marks - Director of Investments. Robbie specializes in identifying promising startups and has a strong background in technology and finance.
Laura Samarze - Manager, Finance and Operations. Laura oversees financial operations and ensures the fund's efficient management.
Andrew Hudon - Senior Associate, Investments. Andrew focuses on sourcing and evaluating investment opportunities within the technology sector.
Sennah Mostovac - Senior Associate, Ecosystem and Operations. Sennah works on building relationships within the innovation ecosystem to support portfolio companies.
Jillian Malcolm - Senior Associate, Investments. Jillian is involved in the investment process and supports portfolio management activities.
To pitch to MaRS IAF, founders should utilize the contact options available on their website. It is advisable to include a detailed business overview in the pitch deck, highlighting the unique value proposition and market potential. Specific response time expectations are not provided, but founders should anticipate a thorough review process.
As of October 2023, MaRS IAF continues to actively invest in early-stage technology companies, maintaining a portfolio of over 100 firms. The fund's focus remains on sectors such as enterprise software, healthtech, cleantech, and deeptech, reflecting its commitment to supporting innovation in these areas.
Recent activities include ongoing evaluations of potential investment opportunities and engagement with founders to provide support and resources. Specific investment announcements or exits have not been detailed, but the fund's proactive approach indicates a strong presence in the North American venture capital landscape.
What are the investment criteria for MaRS IAF?
MaRS IAF focuses on early-stage technology companies across sectors such as enterprise software, healthtech, cleantech, and deeptech. The fund typically invests between C$50K and C$500K, supporting companies from seed stage through growth equity.
How can I apply or pitch to MaRS IAF?
Interested founders can pitch to MaRS IAF through their website. Specific application forms or portals are not detailed, but it is advisable to provide a comprehensive overview of the business and its potential.
What makes MaRS IAF different from other venture capital firms?
MaRS IAF distinguishes itself by offering consistent, long-term support to technology founders. The fund leverages extensive networks and expertise to assist companies in building globally competitive businesses.
What is the geographic scope of MaRS IAF's investments?
The fund primarily invests in North America, with a strong focus on Canadian technology companies. This geographic emphasis allows MaRS IAF to engage deeply with the local innovation ecosystem.
What is the fund size and check size range?
MaRS IAF typically invests between C$50K and C$500K in early-stage companies. The total assets under management (AUM) are not specified, but the fund has a portfolio of over 100 companies.
What kind of post-investment involvement does MaRS IAF have?
While specific details on post-investment involvement are not provided, MaRS IAF is known for leveraging its networks and expertise to support founders in their growth journey, indicating a hands-on approach to portfolio management.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.